These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 34865353)
21. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling. He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523 [TBL] [Abstract][Full Text] [Related]
22. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476 [TBL] [Abstract][Full Text] [Related]
23. Histological features of non-alcoholic fatty liver disease revealed in response to mixed vehicle emission exposure and consumption of a high-fat diet in wildtype C57Bl/6 male mice. Schneider LJ; Santiago I; Johnson B; Stanley AH; Penaredondo B; Lund AK Ecotoxicol Environ Saf; 2023 Aug; 261():115094. PubMed ID: 37285676 [TBL] [Abstract][Full Text] [Related]
24. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis. Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430 [TBL] [Abstract][Full Text] [Related]
25. Effects of high fructose intake on liver injury progression in high fat diet induced fatty liver disease in ovariectomized female mice. Ohashi T; Kato M; Yamasaki A; Kuwano A; Suzuki H; Kohjima M; Ogawa Y Food Chem Toxicol; 2018 Aug; 118():190-197. PubMed ID: 29751074 [TBL] [Abstract][Full Text] [Related]
26. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway. Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893 [TBL] [Abstract][Full Text] [Related]
27. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD. Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487 [TBL] [Abstract][Full Text] [Related]
28. Macrophage-specific FGFR1 deletion alleviates high-fat-diet-induced liver inflammation by inhibiting the MAPKs/TNF pathways. Zhao YN; Liu ZD; Yan T; Xu TX; Jin TY; Jiang YS; Zuo W; Lee KY; Huang LJ; Wang Y Acta Pharmacol Sin; 2024 May; 45(5):988-1001. PubMed ID: 38279043 [TBL] [Abstract][Full Text] [Related]
29. Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis. Ye H; Ma S; Qiu Z; Huang S; Deng G; Li Y; Xu S; Yang M; Shi H; Wu C; Li M; Zhang J; Zhang F; Qin M; Huang H; Zeng Z; Wang M; Chen Y; Lin H; Gao Z; Cai M; Song Y; Gong S; Gao L J Ethnopharmacol; 2022 Oct; 296():115457. PubMed ID: 35753609 [TBL] [Abstract][Full Text] [Related]
30. Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity. Rao Y; Lu YT; Li C; Song QQ; Xu YH; Xu Z; Hu YT; Yu H; Gao L; Gu LQ; Ye JM; Huang ZS Br J Pharmacol; 2019 Aug; 176(16):2877-2893. PubMed ID: 31113010 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic effects of myocardin-related transcription factor A (MRTF-A) knockout on experimental mice with nonalcoholic steatohepatitis induced by high-fat diet. Zhang L; Li HL; Zhang DD; Cui XC Hum Exp Toxicol; 2021 Oct; 40(10):1634-1645. PubMed ID: 33779332 [TBL] [Abstract][Full Text] [Related]
32. Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL/6 mice. Goodarzi G; Tehrani SS; Panahi G; Bahramzadeh A; Meshkani R J Nutr Biochem; 2023 Aug; 118():109369. PubMed ID: 37100305 [TBL] [Abstract][Full Text] [Related]
33. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease. Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819 [TBL] [Abstract][Full Text] [Related]
34. Dectin-1 plays a deleterious role in high fat diet-induced NAFLD of mice through enhancing macrophage activation. Wang MX; Luo W; Ye L; Jin LM; Yang B; Zhang QH; Qian JC; Wang Y; Zhang Y; Liang G Acta Pharmacol Sin; 2023 Jan; 44(1):120-132. PubMed ID: 35689091 [TBL] [Abstract][Full Text] [Related]
35. Assessment of hepatic fatty acids during non-alcoholic steatohepatitis progression using magnetic resonance spectroscopy. Xavier A; Zacconi F; Santana-Romo F; Eykyn TR; Lavin B; Phinikaridou A; Botnar R; Uribe S; Oyarzún JE; Cabrera D; Arrese M; Andia ME Ann Hepatol; 2021; 25():100358. PubMed ID: 33962045 [TBL] [Abstract][Full Text] [Related]
36. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients. Pan X; Wang P; Luo J; Wang Z; Song Y; Ye J; Hou X Endocrine; 2015 Apr; 48(3):834-47. PubMed ID: 25138963 [TBL] [Abstract][Full Text] [Related]
37. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD. Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619 [TBL] [Abstract][Full Text] [Related]
38. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway. Zhang J; Du H; Shen M; Zhao Z; Ye X J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949 [TBL] [Abstract][Full Text] [Related]
39. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700 [TBL] [Abstract][Full Text] [Related]
40. Liver macrophages mediate effects of downhill running and caloric restriction on nonalcoholic fatty liver disease of high fat diet-fed mice. Ai L; Luo W; Yuan P; Liu L; Zhou Y Life Sci; 2020 Sep; 256():117978. PubMed ID: 32553927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]